KALV vs NUE · rev $13.7M vs P/E 25, rev $19.89B
Kalvista Pharmaceuticals Inc (KALV) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
KALV currently screens at market cap $1.44B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the KALV and NUE stock pages for the full models.
Not investment advice.